{"id":"W612583348","doi":"10.1182/blood.v124.21.3094.3094","title":"A Phase I Study of 177 lu-DOTA-HH1 (Betalutin) Radioimmunotherapy for Patients with Relapsed CD37+ Non-Hodgkin's B Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Radioimmunotherapy; Medicine; B cell; DOTA; Lymphoma; Non-Hodgkin's lymphoma; Mantle cell lymphoma; Bone marrow; Cancer research; In vivo; Internal medicine; Antibody; Monoclonal antibody; Immunology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008804947,0.001263559,0.002191838,0.000394833,0.000470898,0.0007542342,0.0008484893,0.0009739599,0.00251605],"category_scores_gemma":[0.0003765032,0.0005086886,0.0009335041,0.0003468584,0.0008217519,0.0005295342,0.0003406922,0.001937707,0.001047629],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00074062,"about_ca_system_score_gemma":0.00128091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009299882,"about_ca_topic_score_gemma":0.001385186,"domain_scores_codex":[0.9997159,0.0001042754,0.00001316102,0.00005312398,0.00002489213,0.00008864646],"domain_scores_gemma":[0.9996588,0.0000415572,0.00003982993,0.00004040816,0.00002239176,0.0001970457],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4001845,0.211707,0.0126793,0.00154937,0.001184441,0.001228209,0.001047172,0.004076925,0.2078756,0.0006154088,0.003888374,0.1539637],"study_design_scores_gemma":[0.1586729,0.8157552,0.01146108,0.00003134141,0.0003195934,0.0005400398,0.00008775192,0.0008808701,0.008713781,0.0001112622,0.003400791,0.00002544693],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992923,0.001123446,0.0006226666,0.0001987173,0.00007372009,0.003401367,0.0004539713,0.00009174439,0.001111386],"genre_scores_gemma":[0.98926,0.001193868,0.001456908,0.0004464703,0.0001158799,0.003748565,0.001301904,0.0000250062,0.002451336],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00251605,"threshold_uncertainty_score":0.00841707,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01103010538261492,"score_gpt":0.28664447928972,"score_spread":0.2756143739071051,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}